MIST - Milestone Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MIST is currently covered by 1 analysts with an average price target of $8.94. This is a potential upside of $6.95 (349.25%) from yesterday's end of day stock price of $1.99.

Milestone Pharmaceuticals's activity chart (see below) currently has 28 price targets and 38 ratings on display. The stock rating distribution of MIST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.57% with an average time for these price targets to be met of 3.6 days.

Highest price target for MIST is $2, Lowest price target is $1.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 01-Apr-2025. First documented stock forecast 02-Jun-2019.

Best performing analysts who are covering MIST - Milestone Pharmaceuticals:

Edward Tenthoff Leland Gershell Chris Howerton Ritu Baral Patrick Trucchio

Currently out of the existing stock ratings of MIST, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

6 months 11 days ago
(01-Apr-2025)

0/2 (0%)

$15.38 (332.90%)

Buy

$9

$7.01 (352.26%)

$32

1 years 9 months 16 days ago
(26-Dec-2023)

0/2 (0%)

$7.12 (378.72%)

Buy

$11

$9.01 (452.76%)

$13

2 years 2 months 2 days ago
(10-Aug-2023)

0/6 (0%)

$7.83 (247.00%)

Hold

$4

$2.01 (101.01%)

$15

2 years 3 months 23 days ago
(19-Jun-2023)

0/3 (0%)

$0.56 (16.28%)

Buy

$10

$8.01 (402.51%)

$10

3 years 5 months 11 days ago
(01-May-2022)

3/7 (42.86%)

$3.85 (62.60%)

18

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MIST (Milestone Pharmaceuticals) average time for price targets to be met?

On average it took 3.6 days on average for the stock forecasts to be realized with a an average price target met ratio 8.57

Which analyst has the current highest performing score on MIST (Milestone Pharmaceuticals) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on MIST (Milestone Pharmaceuticals) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on MIST (Milestone Pharmaceuticals)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on MIST

Which analyst is the currently most bullish on MIST (Milestone Pharmaceuticals)?

Leland Gershell with highest potential upside - $9.01

Which analyst is the currently most reserved on MIST (Milestone Pharmaceuticals)?

Patrick Trucchio with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?